Results for tag: "Drug Device Combination Product"

Drug Device Combination Products (DDCPs) are products that combine a drug with a device to deliver the drug to a patient. These products are used in a variety of drug delivery applications, such as inhalers, transdermal patches, and injectable devices. DDCPs are designed to improve the safety, efficacy, and convenience of drug delivery. They can also reduce the cost of drug delivery by eliminating the need for multiple components. DDCPs are used in a variety of therapeutic areas, including oncology, cardiovascular, and respiratory diseases. They are also used in the delivery of vaccines and other biologics. The global market for DDCPs is expected to grow significantly in the coming years, driven by the increasing prevalence of chronic diseases and the growing demand for more efficient drug delivery systems. Some of the major companies in the DDCP market include 3M, Becton Dickinson, Baxter, Johnson & Johnson, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more